For the quarter ended March 2024, Cencora (COR) reported income of $68.41 billion, up 7.8% over the identical interval final 12 months. EPS got here in at $3.80, in comparison with $3.50 within the year-ago quarter.
The reported income compares to the Zacks Consensus Estimate of $70.35 billion, representing a shock of -2.75%. The corporate delivered an EPS shock of +4.11%, with the consensus EPS estimate being $3.65.
Whereas buyers scrutinize income and earnings modifications year-over-year and the way they examine with Wall Avenue expectations to find out their subsequent transfer, some key metrics all the time provide a extra correct image of an organization’s monetary well being.
Since these metrics play a vital function in driving the top- and bottom-line numbers, evaluating them with the year-ago numbers and what analysts estimated about them helps buyers higher mission a inventory’s worth efficiency.
Right here is how Cencora carried out within the simply reported quarter when it comes to the metrics most generally monitored and projected by Wall Avenue analysts:
- Income- Complete Worldwide Healthcare Options: $7.12 billion versus the four-analyst common estimate of $7.12 billion. The reported quantity represents a year-over-year change of +5.3%.
- Income- Complete U.S. Healthcare Options: $61.29 billion versus $63.32 billion estimated by 4 analysts on common. In comparison with the year-ago quarter, this quantity represents a +8.1% change.
- Income- Intersegment eliminations: -$1.98 million in comparison with the -$1.23 million common estimate primarily based on three analysts. The reported quantity represents a change of +66.5% 12 months over 12 months.
- Income- Worldwide Healthcare Options- Alliance Healthcare: $5.75 billion versus the two-analyst common estimate of $5.04 billion. The reported quantity represents a year-over-year change of +3.5%.
- Income- U.S. Healthcare Options- Animal Well being: $1.31 billion in comparison with the $1.37 billion common estimate primarily based on two analysts. The reported quantity represents a change of +5.6% 12 months over 12 months.
- Income- U.S. Healthcare Options- Human Well being: $59.98 billion versus the two-analyst common estimate of $61.73 billion. The reported quantity represents a year-over-year change of +8.2%.
- Income- Worldwide Healthcare Options- Different Healthcare Options: $1.37 billion versus $1.98 billion estimated by two analysts on common. In comparison with the year-ago quarter, this quantity represents a +13.7% change.
View all Key Company Metrics for Cencora here>>>
Shares of Cencora have returned -1.7% over the previous month versus the Zacks S&P 500 composite’s -4.1% change. The inventory at present has a Zacks Rank #3 (Maintain), indicating that it may carry out in keeping with the broader market within the close to time period.
5 Shares Set to Double
Every was handpicked by a Zacks professional because the #1 favourite inventory to achieve +100% or extra in 2024. Whereas not all picks might be winners, earlier suggestions have soared +143.0%, +175.9%, +498.3% and +673.0%.
A lot of the shares on this report are flying underneath Wall Avenue radar, which offers a terrific alternative to get in on the bottom ground.
Today, See These 5 Potential Home Runs >>
Cencora, Inc. (COR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
